Pricing pressure continues to dampen the US Joint Fluid market, which experienced a double-digit decline of -9.9% according to SmartTRAK's Financial Dashboard results. While the market continues to expand in terms of the number of patients treated, ASPs have steadily eroded over the past three quarters since the Anthem non-coverage decision kicked in earlier this year. Year-to-date, the US Joint Fluid market slowed significantly, posting negative growth according to SmartTRAK estimates...

 

SmartTRAK is so proud of its very latest cutting edge module, Computer-Assisted Surgery, both Spine and Ortho Segments. Elise Wolf, the creator of our Computer-Assisted Surgery Module, launched both in online webinars, the videos which are available to view now! 

Elise Wolf, our Sr. Analyst for Computer Assisted Surgery, led both the webinars and has over 14 years of industry experience in roles including product development, marketing and business development consulting in robotics, emerging medical device technologies and orthopedics.

Please enjoy these overview videos of both modules.

Don't forget! BioMedGPS recently expanded coverage of SmartTRAK Business Intelligence in the realm of Robotic and Computer Assisted Surgery with the launch of the US Computer Assisted Surgery (CAS) – Ortho module on Tuesday, November 13th.

Please join  Elise Wolf, Senior Analyst, Computer Assisted Surgery, for an introductory webinar on SmartTRAK’s newest product:

• Computer Assisted Surgery - Ortho – Tues, Nov. 13 - Register at www.smarttrak.com/cas-ortho

The module provides real time, up-to-date market data, including 5-year market and procedural projections, quarterly revenue tracking, competitive overviews, clinical and regulatory activities and much more.

The new module covers:

• Robotics
• Navigation and surgical planning systems
• Augmented reality technologies 
• Artificial intelligence

The SmartTRAK Robotic and Computer Assisted Surgery module will be managed by Elise Wolf,  a biomedical engineer that worked at a startup out of Carnegie Mellon University on robotic technologies early in her career.

The SmartTRAK analyst team is expanding and we are looking for an experienced and motivated individual who would like to manage one or more of our Regenerative Medicine modules. As you know, all of our SmartTRAK analysts are former marketing, business development or competitive intelligence professionals with one of the major medical device manufacturers and, in fact, most have come to us via recommendations from our subscribers. We believe that having a person of this caliber with relevant experience and deep insight on the market is a tremendous value-add to the SmartTRAK platform.
 
We are specifically interested in a person who wants to work 15-20 hours per week with experience in one or more of the following subject areas:

BioMedGPS, a leading provider of real-time data and analysis in the orthopedic, wound care and neuro therapies markets, is pleased to welcome Amanda Tracy into the role of Chief Commercial Officer. Joining the BioMedGPS leadership team, Ms. Tracy will be responsible for overseeing all sales and marketing initiatives for the company’s highly regarded SmartTRAK Business Intelligence platform.

Ms. Tracy brings with her over 22 years of experience in sales, marketing and business development in both the medical device and pharmaceutical industries. Along with the many relationships she has fostered within the industry, Ms. Tracy brings a unique understanding of the musculoskeletal clinical, regulatory and reimbursement landscapes and the value of integration with each. Prior to joining BioMedGPS, Ms. Tracy worked for 10 years at Musculoskeletal Clinical Regulatory Advisors (MCRA), where she attained the position of Vice President, Global Market Development and was responsible for growing MCRA’s revenues from $100K to $20 million.

“I am delighted to have such a high caliber and seasoned professional as Amanda Tracy lead our commercial efforts,” reports Sharon O’Reilly, President and CEO of BioMedGPS. “Amanda has the breadth of experience and proven expertise needed to bring BioMedGPS to the next level.” 

Volume Up, Pricing Down, Overall Market Lower

Now that Q218 results are in, the US Joint Fluid market continued to experience downward pressure posting negative growth of -6.5% for the quarter and -4.0% YTD, according to SmartTRAK Financial Dashboard results ...

With SmartTRAK, you will always be ahead of the competition.

We just launched SmartTRAK 3.0, the latest version of our premier Business Intelligence Data Platform in the Orthopedics, Wound Care and Neuro Therapies spaces.

It’s here! Cue the confetti. SmartTRAK 3.0 has officially launched today Monday, August 6! We couldn’t be more excited and we have our subscribers to thank.  Why our subscribers, you may ask?

Because our latest iteration of SmartTRAK was inspired by them.

For the past year, we at SmartTRAK have been talking with our subscribers to find out how we could better serve them.  ‘How can we make SmartTRAK even smarter?’ we asked. We learned that users wanted easier access to information and a better overall user experience.

Are you ready for faster, more intuitive business intelligence research experience? An intelligence platform that doesn’t just help you work smarter but actually also makes you smarter?  We are too.

BioMedGPS, the leader in online business intelligence for the Medical Device and Life Science industries, is seeking a Regenerative Medicine Analyst to support SmartTRAK Business Intelligence, an online, comprehensive, easy-to-use, web-based business intelligence solution used by the top 10 orthopedic implant companies and top 15 global wound care manufacturers. SmartTRAK integrates real time market data and analysis accessible throughout an organization, fostering an innovative collaborative approach to market strategy resulting in better decision-making.

We are looking for an experienced, motivated individual with expertise in the Regenerative Medicine market, with knowledge in one or more of the following areas: